Displaying drugs 1551 - 1575 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Perampanel | 349.393 C23H15N3O |  | A non-competitive AMPA glutamate receptor antagonist used to treat partial-onset seizures with or without secondarily generalized seizures, and as adjunctive treatment of primary generalized tonic-clonic seizures in patients with epilepsy. | Noncompetitive AMPA Glutamate Receptor Antagonist / Receptors, AMPA, antagonists & inhibitors |
| Oteseconazole | 527.403 C23H16F7N5O2 |  | An azole antifungal used to prevent recurrent vulvovaginal candidiasis in females who are not of reproductive potential. | Triazole and tetrazole derivatives |
| Cromoglicic acid | 468.3665 C23H16O11 |  | A medication used to treat asthma, allergic reactions of the eyes and nose, as well as other mast cell reactions. | Agents for Dermatitis, Excluding Corticosteroids / Antiallergic Agents, Excl. Corticosteroids |
| Capmatinib | 412.428 C23H17FN6O |  | A kinase inhibitor targeting c-Met receptor tyrosine kinase in the treatment of non-small cell lung cancer with MET exon 14 skipping. | Kinase Inhibitor |
| Vemurafenib | 489.922 C23H18ClF2N3O3S |  | A kinase inhibitor used to treat patients with Erdheim-Chester Disease who have the BRAF V600 mutation, and melanoma in patients who have the BRAF V600E mutation. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors / Sulfonamides |
| Dabrafenib | 519.562 C23H20F3N5O2S2 |  | A kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. | B-Raf serine-threonine kinase (BRAF) inhibitors / Protein Kinase Inhibitors |
| Sulfinpyrazone | 404.482 C23H20N2O3S |  | A platelet inhibitory and uricosuric agent used to inhibit thrombotic and embolic processes and to manage the chronic phases of gout . | Preparations Increasing Uric Acid Excretion |
| Aprepitant | 534.4267 C23H21F7N4O3 |  | A substance P/neurokinin 1 receptor antagonist used to treat nausea and vomiting caused by chemotherapy and surgery. | Antiemetics / Morpholines / Neurokinin-1 Receptor Antagonists / Substance P/Neurokinin-1 Receptor Antagonist |
| Betrixaban | 451.91 C23H22ClN5O3 |  | A Factor Xa inhibitor used for prophylaxis of venous thromboembolism in hospitalized patients. | Direct factor Xa inhibitors |
| Fosaprepitant | 614.4066 C23H22F7N4O6P |  | An antiemetic drug used in combination with other antiemetic agents for the prevention of acute and delayed nausea and vomiting caused by chemotherapy. | Antiemetics / Morpholines / Neurokinin-1 Receptor Antagonists / Substance P/Neurokinin-1 Receptor Antagonist |
| Momelotinib | 414.469 C23H22N6O2 |  | A Janus Kinase inhibitor used to treat intermediate or high-risk myelofibrosis. | Protein Kinase Inhibitors |
| Elvitegravir | 447.884 C23H23ClFNO5 |  | An antiretroviral agent used in combination with other antiretrovirals for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. | Anti-HIV Agents / Anti-Retroviral Agents / HIV Integrase / Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor / Integrase Inhibitors |
| Suvorexant | 450.93 C23H23ClN6O2 |  | A orexin receptor antagonist used to treat insomnia that is characterized by difficulties with sleep onset and/or sleep maintenance. | Orexin Receptor Antagonists / Sleep Aids, Pharmaceutical |
| Daridorexant | 450.93 C23H23ClN6O2 |  | A dual orexin receptor antagonist used to treat insomnia in adults. | Orexin Receptor Antagonists |
| Topotecan | 421.4458 C23H23N3O5 |  | An antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer. | Topoisomerase 1 (TOP1) inhibitors |
| Pralatrexate | 477.4726 C23H23N7O5 |  | An antineoplastic agent used for the treatment of relapsed or refractory peripheral T-cell lymphoma. | Folic Acid Analogues |
| Eprosartan | 424.513 C23H24N2O4S |  | An ARB used to treat hypertension, diabetic nephropathy, and congestive heart failure. | Angiotensin II receptor blockers (ARBs) and diuretics |
| Ozanimod | 404.47 C23H24N4O3 |  | A sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD). | Selective Immunosuppressants |
| Ponesimod | 460.97 C23H25ClN2O4S |  | A sphingosine 1-phosphate receptor modulator indicated to treat relapsing multiple sclerosis. | Selective Immunosuppressants |
| Flupentixol | 434.52 C23H25F3N2OS |  | A thioxanthene neuroleptic used to treat schizophrenia and depression. | Thioxanthene Derivatives |
| Doxazosin | 451.4751 C23H25N5O5 |  | An alpha-1 adrenergic receptor used to treat mild to moderate hypertension and urinary obstruction due to benign prostatic hyperplasia. | Antihypertensive Agents |
| Avanafil | 483.951 C23H26ClN7O3 |  | A phosphodiesterase-5 (PDE5) inhibitor used to treat erectile dysfunction. | Drugs Used in Erectile Dysfunction |
| Fostamatinib | 580.4595 C23H26FN6O9P |  | A spleen tyrosine kinase inhibitor used to treat chronic immune thrombocytopenia after attempting one other treatment. | Amines / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Experimental Unapproved Treatments for COVID-19 / Hemostatics / Kinase Inhibitor / Oxazines / Phosphodiesterase 5 Inhibitors / Pyridines / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors / UGT1A9 Substrates / Vasodilating Agents |
| Solifenacin | 362.473 C23H26N2O2 |  | A muscarinic antagonist with antispasmodic properties used to treat urge urinary incontinence, urgency, and urinary frequency associated with an overactive bladder. | Drugs for Urinary Frequency and Incontinence |
| Aripiprazole | 448.385 C23H27Cl2N3O2 |  | An atypical antipsychotic used in the treatment of a wide variety of mood and psychotic disorders, such as schizophrenia, bipolar I, major depressive disorder, irritability associated with autism, and Tourette's syndrome. | Agents producing tachycardia / Agents that produce hypertension / Neurotoxic agents / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome |
Displaying drugs 1551 - 1575 of 2774 in total